Inhalation Tuesday, July 22, 2014
Skip Navigation LinksHome) Item Details
Inhalation is the only technical publication devoted exclusively to readers involved in development and production of pulmonary or nasal delivered pharmaceuticals.
Technical Articles
   
Item Details:
Publication Date: 06/2011
Pages: 5
Medium:
PDF Format
US:
$7.50
Recommended Item:
The use of cyclodextrins in formulations for lung delivery

Cyclodextrins can solubilize poorly-soluble molecules for delivery in solution inhalers

There are several commercial pharmaceuticals with CyD-based formulations for parenteral use: but as far as it is known there aren’t yet any approved for inhalation delivery to treat diseases of the lung. To improve treatment of lung disease, CyDs can be used to solubilize poorly-soluble molecules for delivery in solution inhalers. Alternatively, these solutions can be spray dried to create particles for inhalation in dry powder inhalers (DPIs). However, the safety of CyD for inhalation would have to be demonstrated.

To read this entire article:

You may purchase this article now for personal use. Simply click the Buy Item button above, enter your payment details, and download the article. It will be available to you for 7 days for viewing, printing, or saving for future reference. All articles are copyrighted by CSC Publishing, Inc. and cannot be used for commercial purposes without express permission in writing from the Publisher. This includes but is not limited to: web posting, printing, or sharing via email.

Security:

Your payment information is forwarded in an encrypted form, using 40- or 128-bit Secure Socket Layer technology, only to our payment gateway (Authorize.net) for processing.

Acrobat:

To view an article, you must have Acrobat Reader installed on your computer. Click on the icon to download Acrobat Reader free of charge.

HyperLink
      Copyright 2014, CSC Publishing Inc. ALL Rights Reserved * Privacy policy